Cutaneous adverse events in multiple sclerosis patients treated with daclizumab
about
Daclizumab high-yield process in the treatment of relapsing-remitting multiple sclerosisCutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple SclerosisInterdisciplinary Risk Management in the Treatment of Multiple Sclerosis.pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity.Daclizumab for the treatment of multiple sclerosis.The future of multiple sclerosis treatments.Dendritic cells in central nervous system autoimmunity.Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis.Daclizumab.Drugs approved for the treatment of multiple sclerosis: review of their safety profile.Daclizumab for the treatment of adults with relapsing forms of multiple sclerosis.
P2860
Q33589947-2833F881-4FD0-48EF-8BBE-BC3DD657A649Q37080630-C3806FCC-0EC5-47CF-B2D0-7E6756FEC406Q37615119-50CA153C-A8BE-4892-8753-6F75184B6980Q37683473-920EDC6D-B639-489F-B3BB-2F15EFA37BFEQ38604207-B466059B-93AF-48B3-938E-97984F48E8AFQ38808485-AA1AD13F-FAA8-42A8-A50E-1D0DC330697BQ39020365-38777510-D495-42CD-A97C-0375F0FA230DQ39434495-4D4202D5-2272-4D58-89EB-C3FA05C1B910Q46487963-6AADCE3B-757B-4DDD-9E83-4ACEB12870B7Q47868767-3F24F138-D187-4811-9619-CC3BC77539C3Q47959279-61C2C567-AA06-4BB7-81E3-AD281210B5F7
P2860
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab
@ast
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab
@en
type
label
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab
@ast
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab
@en
prefLabel
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab
@ast
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab
@en
P2093
P2860
P1433
P1476
Cutaneous adverse events in multiple sclerosis patients treated with daclizumab
@en
P2093
Bibiana Bielekova
Chyi-Chia Lee
Edward W Cowen
Irene Cortese
Joan Ohayon
John J DiGiovanna
Kaylan Fenton
Mark Raffeld
P2860
P304
P356
10.1212/WNL.0000000000002417
P407
P577
2016-02-03T00:00:00Z